Anthony H Nguyen
Examiner (ID: 17425)
Most Active Art Unit | 2854 |
Art Unit(s) | 3307, 2854, 2853 |
Total Applications | 2014 |
Issued Applications | 1600 |
Pending Applications | 48 |
Abandoned Applications | 337 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11677201
[patent_doc_number] => 09675711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-13
[patent_title] => 'Mucus penetrating gene carriers'
[patent_app_type] => utility
[patent_app_number] => 15/144077
[patent_app_country] => US
[patent_app_date] => 2016-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 20968
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15144077
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/144077 | Mucus penetrating gene carriers | May 1, 2016 | Issued |
Array
(
[id] => 12746650
[patent_doc_number] => 20180140717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => TARGETED NANOCARRIERS FOR TARGETED DRUG DELIVERY OF GENE THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 15/570229
[patent_app_country] => US
[patent_app_date] => 2016-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15570229
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/570229 | Targeted nanocarriers for targeted drug delivery of gene therapeutics | Apr 28, 2016 | Issued |
Array
(
[id] => 11120735
[patent_doc_number] => 20160317709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'LIQUEFACTION OF BONE MATRIX'
[patent_app_type] => utility
[patent_app_number] => 15/138384
[patent_app_country] => US
[patent_app_date] => 2016-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16999
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15138384
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/138384 | Liquefaction of bone matrix | Apr 25, 2016 | Issued |
Array
(
[id] => 11066242
[patent_doc_number] => 20160263206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'METHODS AND COMPOSITIONS RELATED TO Th-1 DENDRITIC CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/133204
[patent_app_country] => US
[patent_app_date] => 2016-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 30252
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15133204
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/133204 | Methods and compositions related to T | Apr 18, 2016 | Issued |
Array
(
[id] => 11434668
[patent_doc_number] => 20170035689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'SUBLINGUAL AND BUCCAL FILM COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/069875
[patent_app_country] => US
[patent_app_date] => 2016-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15511
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15069875
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/069875 | Sublingual and buccal film compositions | Mar 13, 2016 | Issued |
Array
(
[id] => 11844784
[patent_doc_number] => 09732329
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-15
[patent_title] => 'Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 15/053992
[patent_app_country] => US
[patent_app_date] => 2016-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 35
[patent_no_of_words] => 22282
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15053992
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/053992 | Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof | Feb 24, 2016 | Issued |
Array
(
[id] => 11085338
[patent_doc_number] => 20160282303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'BENT NANOWIRES AND RELATED PROBING OF SPECIES'
[patent_app_type] => utility
[patent_app_number] => 15/047267
[patent_app_country] => US
[patent_app_date] => 2016-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 26234
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15047267
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/047267 | BENT NANOWIRES AND RELATED PROBING OF SPECIES | Feb 17, 2016 | Abandoned |
Array
(
[id] => 12150015
[patent_doc_number] => 20180021279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'TREATMENT OR PREVENTION OF SURGERY-INDUCED CACHEXIA AND/OR EXPRESSION OF MYELOID-DERIVED SUPPRESSOR CELLS AND PRO-INFLAMMATORY CYTOKINES'
[patent_app_type] => utility
[patent_app_number] => 15/548186
[patent_app_country] => US
[patent_app_date] => 2016-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7615
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548186
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/548186 | Treatment or prevention of surgery-induced cachexia and/or expression of myeloid-derived suppressor cells and pro-inflammatory cytokines | Feb 14, 2016 | Issued |
Array
(
[id] => 11092675
[patent_doc_number] => 20160289643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'Immortalization of Epithelial Cells and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 15/040770
[patent_app_country] => US
[patent_app_date] => 2016-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 18436
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15040770
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/040770 | Immortalization of epithelial cells and methods of use | Feb 9, 2016 | Issued |
Array
(
[id] => 11092676
[patent_doc_number] => 20160289644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'Immortalization of Epithelial Cells and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 15/040783
[patent_app_country] => US
[patent_app_date] => 2016-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 18437
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15040783
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/040783 | Immortalization of epithelial cells and methods of use | Feb 9, 2016 | Issued |
Array
(
[id] => 15267999
[patent_doc_number] => 20190382733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => RECOMBINANT ADENO-ASSOCIATED VIRUS PARTICLE PURIFICATION COMPRISING AN AFFINITY PURIFICATION STEP
[patent_app_type] => utility
[patent_app_number] => 15/549186
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549186
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/549186 | Recombinant adeno-associated virus particle purification comprising an affinity purification step | Feb 8, 2016 | Issued |
Array
(
[id] => 16681913
[patent_doc_number] => 10941380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Biomimetic cell culture substrates
[patent_app_type] => utility
[patent_app_number] => 15/014762
[patent_app_country] => US
[patent_app_date] => 2016-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 32
[patent_no_of_words] => 10011
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15014762
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/014762 | Biomimetic cell culture substrates | Feb 2, 2016 | Issued |
Array
(
[id] => 16336578
[patent_doc_number] => 10787523
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-29
[patent_title] => Nanoparticle-protein complex for intracellular protein delivery
[patent_app_type] => utility
[patent_app_number] => 15/547404
[patent_app_country] => US
[patent_app_date] => 2016-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 47
[patent_no_of_words] => 17319
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15547404
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/547404 | Nanoparticle-protein complex for intracellular protein delivery | Jan 28, 2016 | Issued |
Array
(
[id] => 13339725
[patent_doc_number] => 20180221402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS
[patent_app_type] => utility
[patent_app_number] => 15/545302
[patent_app_country] => US
[patent_app_date] => 2016-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545302
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/545302 | Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells | Jan 20, 2016 | Issued |
Array
(
[id] => 16799057
[patent_doc_number] => 10993972
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-04
[patent_title] => Therapeutic agent for ischemic diseases
[patent_app_type] => utility
[patent_app_number] => 15/544565
[patent_app_country] => US
[patent_app_date] => 2016-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 12337
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15544565
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/544565 | Therapeutic agent for ischemic diseases | Jan 17, 2016 | Issued |
Array
(
[id] => 10767729
[patent_doc_number] => 20160113885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'SUBLINGUAL AND BUCCAL FILM COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/989669
[patent_app_country] => US
[patent_app_date] => 2016-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12053
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14989669
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/989669 | Sublingual and buccal film compositions | Jan 5, 2016 | Issued |
Array
(
[id] => 11429122
[patent_doc_number] => 09567430
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-14
[patent_title] => 'Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery'
[patent_app_type] => utility
[patent_app_number] => 14/988538
[patent_app_country] => US
[patent_app_date] => 2016-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 25
[patent_no_of_words] => 49519
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14988538
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/988538 | Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery | Jan 4, 2016 | Issued |
Array
(
[id] => 10767132
[patent_doc_number] => 20160113287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'NOVEL NYLANDERIA PUBENS VIRUS'
[patent_app_type] => utility
[patent_app_number] => 14/984199
[patent_app_country] => US
[patent_app_date] => 2015-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10719
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14984199
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/984199 | Nylanderia pubens virus | Dec 29, 2015 | Issued |
Array
(
[id] => 12091341
[patent_doc_number] => 20170348435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'NUCLEIC ACID CONSTRUCTS AND GENE THERAPY VECTORS FOR USE IN THE TREATMENT OF WILSON DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/537781
[patent_app_country] => US
[patent_app_date] => 2015-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15899
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15537781
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/537781 | Nucleic acid constructs and gene therapy vectors for use in the treatment of Wilson disease | Dec 16, 2015 | Issued |
Array
(
[id] => 13699805
[patent_doc_number] => 20170360857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => Stable Frozen Virus Formulation
[patent_app_type] => utility
[patent_app_number] => 15/532988
[patent_app_country] => US
[patent_app_date] => 2015-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15532988
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/532988 | Stable Frozen Virus Formulation | Dec 14, 2015 | Abandoned |